← Back to Search

Iron Supplement

Monoferric for Iron Deficiency in Pregnancy

Phase < 1
Waitlist Available
Research Sponsored by Oregon Health and Science University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Iron deficiency anemia, defined as second or third trimester (14 weeks or more) hemoglobin less than or equal to 10.5 g/dL or less than or equal to11 g/dL, respectively, and ferritin less than 50 μg/L
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up from enrollment to 6 weeks post partum
Awards & highlights

Study Summary

This trial studied pregnant women with anemia, difficulty taking iron pills, or nearing the end of their pregnancy.

Who is the study for?
This trial is for pregnant women over 18 with iron deficiency anemia who can't take oral iron or are past 28 weeks of pregnancy. They should have low hemoglobin and ferritin levels indicating anemia, and be willing to participate.Check my eligibility
What is being tested?
The study is observing the effects of Ferric derisomaltose, a type of IV iron treatment, on pregnant women with iron deficiency who either can't tolerate oral iron supplements or are in their late stages of pregnancy.See study design
What are the potential side effects?
While not explicitly listed here, common side effects from IV iron treatments like Ferric derisomaltose may include nausea, dizziness, high blood pressure, flushing, or allergic reactions.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am pregnant, in my second or third trimester, and have low iron levels and hemoglobin.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~from enrollment to 6 weeks post partum
This trial's timeline: 3 weeks for screening, Varies for treatment, and from enrollment to 6 weeks post partum for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
The proportion of participants who experienced a resolution of iron deficiency anemia

Trial Design

1Treatment groups
Experimental Treatment
Group I: Ferric derisomaltoseExperimental Treatment1 Intervention

Find a Location

Who is running the clinical trial?

Oregon Health and Science UniversityLead Sponsor
974 Previous Clinical Trials
7,385,832 Total Patients Enrolled
1 Trials studying Obstetric Labor Complications
100 Patients Enrolled for Obstetric Labor Complications

Media Library

Ferric Derisomaltose (Iron Supplement) Clinical Trial Eligibility Overview. Trial Name: NCT05763043 — Phase < 1
Obstetric Labor Complications Research Study Groups: Ferric derisomaltose
Obstetric Labor Complications Clinical Trial 2023: Ferric Derisomaltose Highlights & Side Effects. Trial Name: NCT05763043 — Phase < 1
Ferric Derisomaltose (Iron Supplement) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05763043 — Phase < 1

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Who would be the ideal candidate for this medical research?

"Eligibility criteria for this study necessitates that participants must have experienced labor difficulties during childbirth, and be aged between 18 to 65. There are 80 spots available in total."

Answered by AI

Is this investigation accommodating elderly participants above the age of eighty?

"The criteria for being part of this medical experiment necessitates that participants fall within the 18 to 65 age bracket. There are also 2 studies targeting youth and 9 catered towards elderly individuals."

Answered by AI

Is enrollment currently being accepted for this clinical investigation?

"Per information from clinicaltrials.gov, this trial is not recruiting new participants at the moment. The study was initially posted on March 15th 2023 and was last updated 28th of February 2023. Nonetheless, there are 14 other medical trials presently enlisting patients for participation."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
Monoferric for Prenatal Iron Deficiency
Ashley Benson 2023. "Monoferric for Prenatal Iron Deficiency". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05763043.
~53 spots leftby Oct 2028
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top